Market Disintermediation: Mergers, Mega Players and Media Hype

Speaker: Dean Erhardt, President, D2 Pharma Consulting

In the changing world of health care, how does one evaluate and understand the current market structure? There is a new world emerging with technology providers (ie, Salesforce, Deloitte, IBM), new payers (ie, CVS-Aetna, Cigna-ESI, Walmart-Humana), and new participants (ie, Google, Apple, Amazon). In this session, Mr Erhardt discusses the ongoing market changes and how these might impact the strategies of manufacturers as they look at their marketing and commercialization options.

Mr Erhardt brings over 30 years of strategy marketing and management experience across both the consumer product and pharmaceutical arenas. Mr Erhardt spent 20 years in various corporate positions with US Healthcare, Cardinal Health, and Express Scripts.

He is the President of D2 Pharma Consulting, which was launched in 2008 and has worked with over 300 manufacturers and 200 specialty pharmacies, launching over 300 products across the pharmaceutical, specialty pharmacy, durable medical equipment, and eHealth spectrum. Mr Erhardt focuses on the company’s distribution and reimbursement initiatives, where D2 supports both the strategic analysis and the tactical execution to attain successful product commercialization.